ELPEN Expands into Middle East Market

ELPEN Expands into Middle East Market

kathimerini.gr

ELPEN Expands into Middle East Market

Greek pharmaceutical company ELPEN expands into the Middle East by establishing a subsidiary in Dubai, driven by market growth and a strategic focus on direct market access.

Greek
Greece
HealthInvestmentGrowthPharmaceuticalsInternational BusinessMarket Expansion
ElpenElpen Pharma Gmbh
Lefteris Tryphon
Why did ELPEN establish a subsidiary in Dubai?
ELPEN, a Greek pharmaceutical company, has established a subsidiary in Dubai, UAE, to expand its reach into the Middle East market.
How does ELPEN's export success support its investment plans?
The 155 million euro investment in research and production facilities in Eastern Attica and Tripoli is supported by the success of ELPEN's export activities.
Describe ELPEN's strategy for international market penetration.
ELPEN's strategic approach involves direct market access in dynamic regions, leveraging its innovative products, quality production, and expertise. This contrasts with utilizing representatives in some markets.
What is the significance of exports to ELPEN's overall performance?
The company's exports account for 60% of its profitability and 70% of its production. In the last two years, sales from markets outside of Greece have increased by 200%.
What factors influenced ELPEN's decision to expand into the Middle East?
ELPEN's expansion into the Middle East is driven by the region's growing market, preference for European products, and stable pricing and reimbursement framework.